Intrinsic	JJ	intrinsic JJ PennPOS
defence	NN	defence NN PennPOS
capacity	NN	capacity NN PennPOS
and	CC	and cc NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
potential	NN	potential NN PennPOS
of	IN	of pp-f NUPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptides	NNS	peptide NNS PennPOS
in	IN	in IN PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
hypertension	NN	hypertension NN PennPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

BACKGROUND	NN	background NN PennPOS
AND	CC	and cc NUPOS
PURPOSE	NN	purpose NN PennPOS
:	:	: : NUPOS
Idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
is	VBZ	be vbz NUPOS
a	DT	a dt NUPOS
progressive	JJ	progressive JJ PennPOS
fibro-proliferative	JJ	fibro-proliferative JJ PennPOS
disorder	NN	disorder NN PennPOS
refractory	JJ	refractory JJ PennPOS
to	TO	to p-acp NUPOS
current	JJ	current JJ PennPOS
therapy	NN	therapy NN PennPOS
commonly	RB	common av-j NUPOS
complicated	VBN	complicate VBN PennPOS
by	IN	by IN PennPOS
the	DT	the dt NUPOS
development	NN	development NN PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
hypertension	NN	hypertension NN PennPOS
(	(	( ( NUPOS
PH	NN	ph NN PennPOS
)	)	) ) NUPOS
;	:	; : NUPOS
the	DT	the dt NUPOS
associated	VBN	associate VBN PennPOS
morbidity	NN	morbidity NN PennPOS
and	CC	and cc NUPOS
mortality	NN	mortality NN PennPOS
are	VBP	be vbb NUPOS
substantial	JJ	substantial JJ PennPOS
.	.	. . NUPOS

Natriuretic	JJ	natriuretic JJ PennPOS
peptides	NNS	peptide NNS PennPOS
possess	VBP	possess VBP PennPOS
vasodilator	NN	vasodilator NN PennPOS
and	CC	and cc NUPOS
anti-fibrotic	JJ	anti-fibrotic JJ PennPOS
actions	NNS	action NNS PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
pharmacological	JJ	pharmacological JJ PennPOS
augmentation	NN	augmentation NN PennPOS
of	IN	of pp-f NUPOS
their	PRP$	their po32 NUPOS
bioactivity	NN	bioactivity NN PennPOS
ameliorates	VBZ	ameliorate VBZ PennPOS
renal	JJ	renal JJ PennPOS
and	CC	and cc NUPOS
myocardial	JJ	myocardial JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

Here	RB	here av NUPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
investigated	VBD	investigate VBD PennPOS
whether	IN	whether cs NUPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptides	NNS	peptide NNS PennPOS
possess	VBP	possess VBP PennPOS
an	DT	a dt NUPOS
intrinsic	JJ	intrinsic JJ PennPOS
cytoprotective	JJ	cytoprotective JJ PennPOS
function	NN	function NN PennPOS
preventing	VBG	prevent VBG PennPOS
the	DT	the dt NUPOS
development	NN	development NN PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
associated	VBN	associate VBN PennPOS
PH	NN	ph NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
whether	IN	whether cs NUPOS
therapeutics	NNS	therapeutic NNS PennPOS
targeting	VBG	target VBG PennPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptide	NN	peptide NN PennPOS
signalling	NN	signalling NN PennPOS
demonstrate	VBP	demonstrate VBP PennPOS
efficacy	NN	efficacy NN PennPOS
in	IN	in IN PennPOS
this	DT	this d NUPOS
life-threatening	JJ	life-threatening JJ PennPOS
disorder	NN	disorder NN PennPOS
.	.	. . NUPOS

EXPERIMENTAL	JJ	experimental JJ PennPOS
APPROACH	NN	approach NN PennPOS
:	:	: : NUPOS
Pulmonary	JJ	pulmonary JJ PennPOS
haemodynamics	NNS	haemodynamic NNS PennPOS
,	,	, , NUPOS
right	JJ	right JJ PennPOS
ventricular	JJ	ventricular JJ PennPOS
function	NN	function NN PennPOS
and	CC	and cc NUPOS
markers	NNS	marker NNS PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
were	VBD	be vbd NUPOS
determined	VBN	determine VBN PennPOS
in	IN	in IN PennPOS
wild-type	JJ	wild-type JJ PennPOS
(	(	( ( NUPOS
WT	JJ	wt JJ PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptide	NN	peptide NN PennPOS
receptor	NN	receptor NN PennPOS
(	(	( ( NUPOS
NPR	NN	npr NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
A	DT	a dt NUPOS
knockout	NN	knockout NN PennPOS
(	(	( ( NUPOS
KO	NN	ko NN PennPOS
)	)	) ) NUPOS
mice	NNS	mouse n2 NUPOS
exposed	VBN	expose VBN PennPOS
to	TO	to p-acp NUPOS
bleomycin	NN	bleomycin NN PennPOS
(	(	( ( NUPOS
1	CD	1 crd NUPOS
mg	NN	mg NN PennPOS
kg	NN	kg NN PennPOS
(	(	( ( NUPOS
-1	CD	-1 CD PennPOS
)	)	) ) NUPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Human	JJ	human JJ PennPOS
myofibroblast	NN	myofibroblast NN PennPOS
differentiation	NN	differentiation NN PennPOS
was	VBD	be vbd NUPOS
studied	VBN	study VBN PennPOS
in	FW	in fw-la NUPOS
vitro	FW	vitro FW PennPOS
.	.	. . NUPOS

KEY	JJ	key JJ PennPOS
RESULTS	NNS	result NNS PennPOS
:	:	: : NUPOS
Exacerbated	VBN	exacerbate VBN PennPOS
cardiac	JJ	cardiac JJ PennPOS
,	,	, , NUPOS
vascular	JJ	vascular JJ PennPOS
and	CC	and cc NUPOS
fibrotic	JJ	fibrotic JJ PennPOS
pathology	NN	pathology NN PennPOS
was	VBD	be vbd NUPOS
observed	VBN	observe VBN PennPOS
in	IN	in IN PennPOS
NPR-A	NN	NPR-A NN PennPOS
KO	NN	ko NN PennPOS
animals	NNS	animal NNS PennPOS
,	,	, , NUPOS
compared	VBN	compare VBN PennPOS
with	IN	with pp NUPOS
WT	JJ	wt JJ PennPOS
mice	NNS	mouse n2 NUPOS
,	,	, , NUPOS
exposed	VBN	expose VBN PennPOS
to	TO	to p-acp NUPOS
bleomycin	NN	bleomycin NN PennPOS
.	.	. . NUPOS

Treatment	NN	treatment NN PennPOS
with	IN	with pp NUPOS
a	DT	a dt NUPOS
drug	NN	drug NN PennPOS
combination	NN	combination NN PennPOS
that	WDT	that WDT PennPOS
raised	VBD	raise VBD PennPOS
circulating	VBG	circulate VBG PennPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptide	NN	peptide NN PennPOS
levels	NNS	level NNS PennPOS
(	(	( ( NUPOS
ecadotril	NN	ecadotril NN PennPOS
)	)	) ) NUPOS
and	CC	and cc NUPOS
potentiated	VBD	potentiate VBD PennPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptide-dependent	JJ	peptide-dependent JJ PennPOS
signalling	NN	signalling NN PennPOS
(	(	( ( NUPOS
sildenafil	NN	sildenafil NN PennPOS
)	)	) ) NUPOS
reduced	VBD	reduce VBD PennPOS
indices	NNS	index NNS PennPOS
of	IN	of pp-f NUPOS
disease	NN	disease NN PennPOS
progression	NN	progression NN PennPOS
,	,	, , NUPOS
whether	IN	whether cs NUPOS
administered	VBN	administer VBN PennPOS
prophylactically	RB	prophylactical RB PennPOS
or	CC	or cc NUPOS
to	TO	to p-acp NUPOS
animals	NNS	animal NNS PennPOS
with	IN	with pp NUPOS
established	JJ	established JJ PennPOS
lung	NN	lung NN PennPOS
disease	NN	disease NN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
positive	JJ	positive JJ PennPOS
pharmacodynamic	JJ	pharmacodynamic JJ PennPOS
effect	NN	effect NN PennPOS
was	VBD	be vbd NUPOS
diminished	VBN	diminish VBN PennPOS
in	IN	in IN PennPOS
NPR-A	NN	NPR-A NN PennPOS
KO	NN	ko NN PennPOS
mice	NNS	mouse n2 NUPOS
.	.	. . NUPOS

Atrial	JJ	atrial JJ PennPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptide	NN	peptide NN PennPOS
and	CC	and cc NUPOS
sildenafil	NN	sildenafil NN PennPOS
synergistically	RB	synergistic av-j NUPOS
reduced	VBD	reduce VBD PennPOS
TGFb-induced	JJ	tgfb-induced JJ PennPOS
human	JJ	human JJ PennPOS
myofibroblast	NN	myofibroblast NN PennPOS
differentiation	NN	differentiation NN PennPOS
,	,	, , NUPOS
a	DT	a dt NUPOS
key	JJ	key JJ PennPOS
driver	NN	driver NN PennPOS
of	IN	of pp-f NUPOS
remodelling	NN	remodelling NN PennPOS
in	IN	in IN PennPOS
IPF	NN	IPF NN PennPOS
patients	NNS	patient NNS PennPOS
.	.	. . NUPOS

CONCLUSIONS	NNS	conclusion NNS PennPOS
AND	CC	and cc NUPOS
IMPLICATIONS	NNS	implication NNS PennPOS
:	:	: : NUPOS
These	DT	these d NUPOS
data	NNS	datum NNS PennPOS
highlight	VBP	highlight VBP PennPOS
an	DT	a dt NUPOS
endogenous	JJ	endogenous JJ PennPOS
host-defence	NN	host-defence NN PennPOS
capacity	NN	capacity NN PennPOS
of	IN	of pp-f NUPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptides	NNS	peptide NNS PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
PH.	NN	PH. NN PennPOS
A	DT	a dt NUPOS
combination	NN	combination NN PennPOS
of	IN	of pp-f NUPOS
ecadotril	NN	ecadotril NN PennPOS
and	CC	and cc NUPOS
sildenafil	NN	sildenafil NN PennPOS
reversed	VBD	reverse VBD PennPOS
the	DT	the dt NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
haemodynamic	JJ	haemodynamic JJ PennPOS
aberrations	NNS	aberration NNS PennPOS
and	CC	and cc NUPOS
remodelling	VBG	remodel VBG PennPOS
that	IN	that cst NUPOS
characterize	VBP	characterize VBP PennPOS
the	DT	the dt NUPOS
disease	NN	disease NN PennPOS
,	,	, , NUPOS
advocating	VBG	advocate VBG PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
manipulation	NN	manipulation NN PennPOS
of	IN	of pp-f NUPOS
natriuretic	JJ	natriuretic JJ PennPOS
peptide	NN	peptide NN PennPOS
bioactivity	NN	bioactivity NN PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

